Cite
Patel SB, Nemkov T, Stefanoni D, et al. Metabolic alterations mediated by STAT3 promotes drug persistence in CML. Leukemia. 2021;35(12):3371-3382doi: 10.1038/s41375-021-01315-0.
Patel, S. B., Nemkov, T., Stefanoni, D., Benavides, G. A., Bassal, M. A., Crown, B. L., Matkins, V. R., Camacho, V., Kuznetsova, V., Hoang, A. T., Tenen, D. E., Wolock, S. L., Park, J., Ying, L., Yue, Z., Chen, J. Y., Yang, H., Tenen, D. G., Ferrell, P. B., Lu, R., Darley-Usmar, V., D'Alessandro, A., Bhatia, R., & Welner, R. S. (2021). Metabolic alterations mediated by STAT3 promotes drug persistence in CML. Leukemia, 35(12), 3371-3382. https://doi.org/10.1038/s41375-021-01315-0
Patel, Sweta B, et al. "Metabolic alterations mediated by STAT3 promotes drug persistence in CML." Leukemia vol. 35,12 (2021): 3371-3382. doi: https://doi.org/10.1038/s41375-021-01315-0
Patel SB, Nemkov T, Stefanoni D, Benavides GA, Bassal MA, Crown BL, Matkins VR, Camacho V, Kuznetsova V, Hoang AT, Tenen DE, Wolock SL, Park J, Ying L, Yue Z, Chen JY, Yang H, Tenen DG, Ferrell PB, Lu R, Darley-Usmar V, D'Alessandro A, Bhatia R, Welner RS. Metabolic alterations mediated by STAT3 promotes drug persistence in CML. Leukemia. 2021 Dec;35(12):3371-3382. doi: 10.1038/s41375-021-01315-0. Epub 2021 Jun 12. PMID: 34120146; PMCID: PMC8632690.
Copy
Download .nbib